CGD in the News

Why the WHO approval of the first malaria vaccine is a big deal

October 06, 2021

Every year, malaria kills more than 400,000 people, most of them children. There has been significant progress against the disease in the past few decades — death rates have fallen nearly in half since 2000 — but there’s still a long way to go. For decades, researchers have been working on developing a vaccine. It hasn’t been easy. Malaria, a parasite infection, is hard to vaccinate against, and many attempted vaccines haven’t produced durable immunity.

“Many global health organizations have worked long and hard to make an efficacious malaria vaccine a reality. There’s still an imperative to sustain existing interventions alongside, so we’ll be looking for donors to up their total contributions to fight against malaria to incorporate this new tool into their armaments,” Amanda Glassman, the executive vice president at the Center for Global Development, said in a statement.